AI Generated Image
New FDA peptide advisers could benefit from their own rulings
statnews.com • • business
Key Points:
- The FDA announced eight new panelists for a committee that will advise on allowing compounding pharmacies to manufacture certain peptides.
- Most of the new members have ties to businesses that promote and prescribe peptides, potentially influencing rules that could benefit their interests.
- Among the appointees is Bobby Harshbarger, a pharmacist and Tennessee state senator, who is the son of U.S. Rep. Diana Harshbarger, a pharmacist advocating for reduced peptide regulation.
